PATENT CLAIM ANALYSIS

Application Number: 15922815
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["536", "111000"]

Abstract:
The present application provides a pharmaceutical composition for use in inhibiting recurrence, aggravation or metastasis of liver cancer, in which the pharmaceutical composition comprises at least one compound having a structure of formula (I) and a pharmaceutically acceptable vehicle.

Claim (Index 18):
The method of  claim 17 , further comprising:\n administering to the patient at least one additional therapy for inhibiting recurrence, aggravation or metastasis of liver cancer, the at least one additional therapy is selected from the group consisting of embolization therapy, target drug therapy, chemotherapy, and radiation therapy; or removing all or a portion of the liver of the patient.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 90.0
- Lexical Diversity: 1.18919
- Patent Class: 536.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14901297', '15614412', '15651060', '15179153', '15613711']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6082986080099362
- 35 USC 102 Novelty (BERT): 0.4866914062155957
- Combined Prediction Score: 0.5961378878305021
- Mean Citation Score: 197.529832
- Max Citation Score: 203.69781
- Similarity Product: 138.93194351644993

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test